Kimal plc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Kimal plc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011168
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kimal plc (Kimal) is a medical equipment company that develops, manufactures and markets customised procedure packs and vascular access devices. The company’s products include soft tissue biopsy needles, bone marrow biopsy needles, catheter accessories, catheter lock solution, closure device, drainage products, fluid management, drapes, gowns and equipment covers. It also provides infusion systems, haemodialysis monitor and guidewires, among others. Kimal offers services such as product training, customer care and ordering information, patient scheduled management services and business to business services, among others. The company’s products are used in the therapeutic areas of cardiology, critical care, radiology, renal, oncology, hematology, nutrition and others. It operates in the UAE and the UK. Kimal is headquartered in Uxbridge, the UK.

Kimal plc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kimal plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Kimal plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Kimal plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Kimal plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Kimal plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Kimal plc, Medical Equipment, Deal Details 10
Partnerships 10
Kimal Extends Distribution Agreement With AngioDynamics For Vascular Access Products 10
Kimal Extends Distribution Agreement With Tauropharm For Taurolock 11
Kimal Enters Into Distribution Agreement With AngioDynamics For Fluid Management And Vascular Products 12
Actuated Medical Enters Into Co-Marketing Agreement With Kimal For TubeClear System 13
Kimal plc – Key Competitors 14
Kimal plc – Key Employees 15
Kimal plc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Jul 13, 2017: Kimal prepares for further expansion 17
Corporate Communications 18
Jan 05, 2017: Kimal announce the appointment of Geoff Morris OBE 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Kimal plc, Medical Equipment, Key Facts, 2016 2
Kimal plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Kimal plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Kimal plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Kimal plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Kimal plc, Deals By Market, 2011 to YTD 2017 8
Kimal plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Kimal Extends Distribution Agreement With AngioDynamics For Vascular Access Products 10
Kimal Extends Distribution Agreement With Tauropharm For Taurolock 11
Kimal Enters Into Distribution Agreement With AngioDynamics For Fluid Management And Vascular Products 12
Actuated Medical Enters Into Co-Marketing Agreement With Kimal For TubeClear System 13
Kimal plc, Key Competitors 14
Kimal plc, Key Employees 15
Kimal plc, Other Locations 16
Kimal plc, Subsidiaries 16

★海外企業調査レポート[Kimal plc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UMN Pharma Inc (4585):企業の財務・戦略的SWOT分析
    Summary UMN Pharma Inc (UMN Pharma), a subsidiary of Shionogi Inc, is a biopharmaceutical company that manufactures therapeutic for muscular dystrophy, diabetes and influenza. The company’s pipeline products include UMN-101 for the treatment of Recombinant seasonal influenza vaccine; UMN-102 for rec …
  • Navamedic ASA (NAVA):企業の財務・戦略的SWOT分析
    Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • VION N.V.:企業の戦略・SWOT・財務情報
    VION N.V. - Strategy, SWOT and Corporate Finance Report Summary VION N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Glanbia Nutritionals Inc:企業の戦略的SWOT分析
    Glanbia Nutritionals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • ROHA Dyechem Pvt. Ltd.:戦略・SWOT・企業財務分析
    ROHA Dyechem Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary ROHA Dyechem Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Adecco Group AG :企業の戦略・SWOT・財務情報
    Adecco Group AG - Strategy, SWOT and Corporate Finance Report Summary Adecco Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • APEIRON Biologics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary APEIRON Biologics AG (APEIRON) is a clinical-stage biotechnology company that concentrates on the development of biological and immunological solutions for the treatment of various cancers. The company’s pipeline products include APN01, APN301, APN311, APN401, APN411, APN421 and APN431. Its …
  • ReShape Medical Inc-製薬・医療分野:企業M&A・提携分析
    Summary ReShape Medical Inc (ReShape Medical) is a medical device company that offers weight loss solutions. The company provides dual intragastric balloon for weight loss. Its product comprises of ReShape Duo, a non surgical dual-intragastric balloon used in the treatment of obese or overweight pat …
  • Bayer HealthCare Pharmaceuticals:医療機器:M&Aディール及び事業提携情報
    Summary Bayer HealthCare Pharmaceuticals (Bayer Healthcare), formerly Bayer Schering Pharma AG, a subsidiary of Bayer AG, is the pharmaceutical company that develops, manufactures and markets prescription products in the areas of general medicine and specialty medicine. The company offer prescriptio …
  • Gr. Sarantis S.A. (SAR):企業の財務・戦略的SWOT分析
    Gr. Sarantis S.A. (SAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • ALFA, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary ALFA, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • DIA Imaging Analysis Ltd:医療機器:M&Aディール及び事業提携情報
    Summary DIA Imaging Analysis Ltd (DIA Imaging Analysis), formerly DiACardio Ltd is a provider of medical imaging solutions. The company’s products comprise LVivo SWM, LVivo EF, and LVivo Strain. Its LVivo SWM is a fully automated echo device or PACS systems. DiACardio’s LVivo platform comprises tool …
  • ZoomMed Inc (ZMD)-医療機器分野:企業M&A・提携分析
    Summary ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pat …
  • Orca Gold Inc (ORG):企業の財務・戦略的SWOT分析
    Summary Orca Gold Inc (Orca Gold), formerly Canaco Resources Inc, subsidiary of Pinetree Capital Ltd, is a gold exploration company. The company's activities include acquisition, exploration and development of mineral properties in North and West Africa. It holds interests in The Block 14 gold proje …
  • Cantabio Pharmaceuticals Inc (CTBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Cantabio Pharmaceuticals Inc (Cantabio Pharmaceuticals) is a biotechnology company that concentrates on the commercializing of novel therapies for Parkinson’s disease, Alzheimer’s disease and neurodegenerative diseases. The company provide pipeline product candidates such as CB101 and CB102, …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Retail Food Group Limited (Foodservice):企業の戦略・SWOT・財務分析
    Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Sellier & Bellot J.S.C.:企業の戦略・SWOT・財務分析
    Sellier & Bellot J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Sellier & Bellot J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Norwest Venture Partners XII, LP:企業のM&A・事業提携・投資動向
    Norwest Venture Partners XII, LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norwest Venture Partners XII, LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Massachusetts General Hospital:企業のM&A・事業提携・投資動向
    Massachusetts General Hospital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Massachusetts General Hospital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆